Literature DB >> 25703268

Epidemiology of musculoskeletal tumors in a national referral orthopedic department. A study of 3482 cases.

Marko Bergovec1, Ozren Kubat2, Miroslav Smerdelj2, Sven Seiwerth3, Aleksandra Bonevski4, Dubravko Orlic2.   

Abstract

AIM OF THE STUDY: Musculoskeletal tumors are relatively rare, and their geographic distribution varies greatly around the world. In this study, we present the incidence, age distribution and localization of musculoskeletal tumors diagnosed and/or treated at a tertiary referral orthopedic department, catering to an entire Southeastern European country.
METHODS: This was a retrospective study of prospectively collected data, in which all patients diagnosed and/or treated for musculoskeletal tumors at our Department in the period of 30 years (1981-2010) were included.
RESULTS: Data of a total of 3482 patients with musculoskeletal tumors were collected. Average age of patients was 33.5 years (range, 2 months-88 years), with even distribution according to sex. Malignant tumors were seen in 20.7% of patients, more often in men (56.9%). Most common malignant tumors were osteosarcoma (estimated incidence: 1.68/million/year), chondrosarcoma (0.79/million/year) and Ewing sarcoma (0.76/million/year). Benign tumors and tumor-like lesions were found in 79.3% of patients, with slight female predominance. Most common benign bone lesions were osteochondroma (5.81/million/year), simple bone cyst (2.13/million/year), and enchondroma (2.05/million/year).
CONCLUSION: This report represents a first of its kind in our region, and gives representative results to be compared to other middle and south European countries. Further nationwide studies are needed to improve strategies in bone tumor diagnosis and treatment.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone cysts; Chondroma; Chondrosarcoma; Ewing; Incidence; Osteochondroma; Osteosarcoma; Sarcoma

Mesh:

Year:  2015        PMID: 25703268     DOI: 10.1016/j.canep.2015.01.015

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  8 in total

1.  Patellar dislocation following distal femoral replacement after extra-articular knee resection for bone sarcoma: A case report.

Authors:  Yuta Kubota; Kazuhiro Tanaka; Masashi Hirakawa; Tatsuya Iwasaki; Masanori Kawano; Ichiro Itonaga; Hiroshi Tsumura
Journal:  World J Clin Cases       Date:  2022-04-16       Impact factor: 1.534

2.  Decoration of Squalenoyl-Gemcitabine Nanoparticles with Squalenyl-Hydroxybisphosphonate for the Treatment of Bone Tumors.

Authors:  Carlos Rodríguez-Nogales; Didier Desmaële; Víctor Sebastián; Patrick Couvreur; María J Blanco-Prieto
Journal:  ChemMedChem       Date:  2021-10-22       Impact factor: 3.540

3.  Osteochondroma: Review of 431 patients from one medical institution in South China.

Authors:  Kai Tong; Hongzhe Liu; Xiang Wang; Ziyi Zhong; Shenglu Cao; Chengjie Zhong; YunPing Yang; Gang Wang
Journal:  J Bone Oncol       Date:  2017-08-30       Impact factor: 4.072

4.  Primary bone sarcomas in KSA: A Saudi tumor registry review.

Authors:  Wazzan S Aljuhani; Abdullah M Alanazi; Mohammad A Alghafees
Journal:  J Taibah Univ Med Sci       Date:  2020-12-01

Review 5.  UK guidelines for the management of bone sarcomas.

Authors:  Craig Gerrand; Nick Athanasou; Bernadette Brennan; Robert Grimer; Ian Judson; Bruce Morland; David Peake; Beatrice Seddon; Jeremy Whelan
Journal:  Clin Sarcoma Res       Date:  2016-05-04

6.  Reconstruct the proximal radius with iliac graft and elastic intramedullary nail fixation after tumor resection.

Authors:  Bin Zhu; Jielai Yang; Dongdong Cheng; Xiaofan Yin; Qingcheng Yang
Journal:  World J Surg Oncol       Date:  2016-08-08       Impact factor: 2.754

7.  Chondrosarcoma of the patella: A case report.

Authors:  Conglin Ye; Zhiping Luo; Jin Zeng; Min Dai
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

8.  Battle Against Musculoskeletal Tumors: Descriptive Data of Military Hospital Experience.

Authors:  Cagri Neyisci; Yusuf Erdem
Journal:  Front Public Health       Date:  2020-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.